Nanomi B.V.

Nanomi is a leader in the field of microsphere and nanoparticle manufacture and development of long-acting release medicines. The company earned this unique position by focusing not only on high-quality research, but also on the development of a pipeline of products based on its proprietary Microsieve technology, both in-house and in collaboration with partners.

Nanomi has developed a cutting-edge technology - the Microsieve technology - for the development of long-acting release medicines, a technology that offers unprecedented drug development potential for the future. The Microsieve technology is unique in that it guarantees production of medicines with uniform particle size, uniform particle shape and uniform biological properties. These properties safeguard precise dosing of the medicines over long periods of time. The technology is proven robust, scalable and cost effective, and is applicable to a myriad of pharmaceutical compounds. It represents an unprecedented potential in development of long-acting release medicines. With the Microsieve technology, Nanomi offers reliable solutions for complex challenges in the pharmaceutical industry.